Back to search

Incidence of Bloodstream Infections Due to Candida Species and In Vitro Susceptibilities of Isolates Collected from 1998 to 2000 in a Population-Based Active Surveillance Program

Data up to Jan 2025

Published2004
Citations655
References51

Total Citations Per Year

Abstract

References (51)

Manual of Clinical Microbiology.

1980 • 14,937 citations

Manual of Clinical Microbiology, 7th ed.

2000 • 1,651 citations

Nosocomial Bloodstream Infections in United States Hospitals: A Three‐Year Analysis

1999 • 1,400 citations

Attributable Mortality of Nosocomial Candidemia, Revisited

2003 • 1,132 citations

A Randomized Trial Comparing Fluconazole with Amphotericin B for the Treatment of Candidemia in Patients without Neutropenia

1994 • 1,040 citations

Secular trends in nosocomial primary bloodstream infections in the United States, 1980–1989

1991 • 896 citations

The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance

1996 • 779 citations

The Epidemiology of Hematogenous Candidiasis Caused by Different Candida Species

1997 • 774 citations

Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences

2002 • 769 citations

Secular Trend of Hospital‐Acquired Candidemia among Intensive Care Unit Patients in the United States during 1989–1999

2002 • 661 citations

Candidemia in Cancer Patients: A Prospective, Multicenter Surveillance Study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC)

1999 • 613 citations

Risk factors for candidemia in Neonatal Intensive Care Unit patients

2000 • 572 citations

Importance of Candida Species Other than C. albicans as Pathogens in Oncology Patients

1995 • 562 citations

International Surveillance of Bloodstream Infections Due to Candida Species: Frequency of Occurrence and In Vitro Susceptibilities to Fluconazole, Ravuconazole, and Voriconazole of Isolates Collected from 1997 through 1999 in the SENTRY Antimicrobial Surveillance Program

2001 • 527 citations

Risk factors for hospital-acquired candidemia. A matched case-control study

1989 • 520 citations

Fluconazole Prophylaxis against Fungal Colonization and Infection in Preterm Infants

2001 • 517 citations

Candidemia in Allogeneic Blood and Marrow Transplant Recipients: Evolution of Risk Factors after the Adoption of Prophylactic Fluconazole

2000 • 506 citations

The Epidemiology of Candidemia in Two United States Cities: Results of a Population-Based Active Surveillance

1999 • 468 citations

National Surveillance of Nosocomial Blood Stream Infection Due to Species of Candida Other than Candida albicans: Frequency of Occurrence and Antifungal Susceptibility in the SCOPE Program

1998 • 427 citations

Candida parapsilosis: Epidemiology, Pathogenicity, Clinical Manifestations, and Antimicrobial Susceptibility

1992 • 399 citations

Epidemiology of Candidemia: 3-Year Results from the Emerging Infections and the Epidemiology of Iowa Organisms Study

2002 • 386 citations

Has Antifungal Susceptibility Testing Come of Age?

2002 • 357 citations

Risk Factors for Hospital-Acquired Candidemia

1989 • 337 citations

National Surveillance of Nosocomial Blood Stream Infection Due to Candida albicans: Frequency of Occurrence and Antifungal Susceptibility in the SCOPE Program

1998 • 335 citations

The Impact of Candidemia on Length of Hospital Stay, Outcome, and Overall Cost of Illness

1998 • 323 citations

Trends in Antifungal Susceptibility of Candida spp. Isolated from Pediatric and Adult Patients with Bloodstream Infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000

2002 • 322 citations

Role of Sentinel Surveillance of Candidemia: Trends in Species Distribution and Antifungal Susceptibility

2002 • 277 citations

Aspergillus fumigatuscell wall: composition and biosynthesis

2001 • 277 citations

Candidemia at a Tertiary-Care Hospital: Epidemiology, Treatment, Clinical Outcome and Risk Factors for Death

2002 • 252 citations

Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period

1994 • 241 citations

The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer

2002 • 211 citations

Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: enhanced ability to detect amphotericin B-resistant Candida isolates

1995 • 200 citations

Yeast identification in the clinical microbiology laboratory: phenotypical methods

2001 • 183 citations

Risk Factors for Death in Patients with Candidemia

1998 • 167 citations

Epidemiology of candidemia.

2000 • 161 citations

Rapid Identification of Candida Species with Species-Specific DNA Probes

1998 • 158 citations

National Epidemiology of Mycoses Survey: A Multicenter Study of Strain Variation and Antifungal Susceptibility Among Isolates of Candida Species

1998 • 147 citations

Secular Trends of Candidemia Over 12 Years in Adult Patients at a Tertiary Care Hospital

2002 • 141 citations

In Vitro Activities of 5-Fluorocytosine against 8,803 Clinical Isolates of Candida spp.: Global Assessment of Primary Resistance Using National Committee for Clinical Laboratory Standards Susceptibility Testing Methods

2002 • 125 citations

European Confederation of Medical Mycology (ECMM) prospective survey of candidaemia: report from one Italian region

2002 • 123 citations

Candidemia in French hospitals: incidence rates and characteristics

2002 • 119 citations

Candida dubliniensisFungemia: the First Four Cases in North America

2000 • 108 citations

Risk Factors for Death in Patients with Candidemia

1998 • 96 citations

Evaluation of etest for determining in vitro susceptibility of yeast isolates to amphotericin B

1998 • 91 citations

Monitoring hospital-acquired infections to promote patient safety--United States, 1990-1999.

2000 • 91 citations

Correlation between In Vitro Susceptibility Determined by E Test and Response to Therapy with Amphotericin B: Results from a Multicenter Prospective Study of Candidemia

1999 • 90 citations

Improved Detection of Amphotericin B-Resistant Isolates of Candida lusitaniae by Etest

2001 • 80 citations

Invasive Candidiasis: Turning Risk into a Practical Prevention Policy?

2001 • 79 citations

Evaluation of a Reformulated CHROMagar Candida

2001 • 53 citations

Risk of low birth weight infants among black and white parents

1998 • 53 citations

Resolution of Discrepant Results for Candida Species Identification by Using DNA Probes

2004 • 44 citations

Cited By (0)

Loading...